Acadian Asset Management LLC Aptevo Therapeutics Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021
SELL
$27.86 - $40.59 $86,254 - $125,666
-3,096 Closed
0 $0
Q4 2020

Feb 11, 2021
SELL
$6.21 - $48.36 $261,006 - $2.03 Million
-42,030 Reduced 93.14%
3,096 $113,000
Q3 2020

Nov 09, 2020
SELL
$7.21 - $9.37 $8,385 - $10,897
-1,163 Reduced 2.51%
45,126 $344,000
Q2 2020

Aug 12, 2020
BUY
$3.11 - $9.27 $143,958 - $429,099
46,289 New
46,289 $386,000

About Aptevo Therapeutics Inc.

APVO Quotes by TradingView
  • Ticker APVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,090,640
  • Market Cap $24.5M
  • Description
  • Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1b clinical trial for acute myelogenous leukemia and myelo...
More about APVO
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email